These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253 [TBL] [Abstract][Full Text] [Related]
5. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997 [TBL] [Abstract][Full Text] [Related]
6. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice. Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323 [TBL] [Abstract][Full Text] [Related]
7. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient. Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738 [TBL] [Abstract][Full Text] [Related]
8. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8 Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435 [TBL] [Abstract][Full Text] [Related]
9. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors. Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771 [TBL] [Abstract][Full Text] [Related]
10. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection. Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528 [TBL] [Abstract][Full Text] [Related]
11. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection. Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209 [TBL] [Abstract][Full Text] [Related]
12. Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus. O'Connell KA; Brennan TP; Bailey JR; Ray SC; Siliciano RF; Blankson JN J Virol; 2010 Jul; 84(14):7018-28. PubMed ID: 20444904 [TBL] [Abstract][Full Text] [Related]
13. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV. Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843 [TBL] [Abstract][Full Text] [Related]
14. HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. Kloverpris HN; Stryhn A; Harndahl M; van der Stok M; Payne RP; Matthews PC; Chen F; Riddell L; Walker BD; Ndung'u T; Buus S; Goulder P J Virol; 2012 Jan; 86(2):919-29. PubMed ID: 22090105 [TBL] [Abstract][Full Text] [Related]
15. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals. Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744 [TBL] [Abstract][Full Text] [Related]
16. Selection of TI8-8V mutant associated with long-term control of HIV-1 by cross-reactive HLA-B*51:01-restricted cytotoxic T cells. Kuse N; Akahoshi T; Gatanaga H; Ueno T; Oka S; Takiguchi M J Immunol; 2014 Nov; 193(10):4814-22. PubMed ID: 25305317 [TBL] [Abstract][Full Text] [Related]
17. Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape. Bailey JR; Zhang H; Wegweiser BW; Yang HC; Herrera L; Ahonkhai A; Williams TM; Siliciano RF; Blankson JN J Infect Dis; 2007 Jul; 196(1):50-5. PubMed ID: 17538883 [TBL] [Abstract][Full Text] [Related]
18. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57. Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088 [TBL] [Abstract][Full Text] [Related]